Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 27;8(2):201-203.
doi: 10.1016/j.jacbts.2022.10.005. eCollection 2023 Feb.

Type 2 Diabetes Mellitus Treatment and Beyond: A Glance in Our Armamentarium

Affiliations
Editorial

Type 2 Diabetes Mellitus Treatment and Beyond: A Glance in Our Armamentarium

Konstantinos Iliodromitis et al. JACC Basic Transl Sci. .

Abstract

,

Keywords: atherosclerosis; liraglutide; molecular imaging; ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
None
Graphical abstract

Comment on

References

    1. Cosentino F., Grant P.J., Aboyans V., et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41:255–323. - PubMed
    1. Khan M.S., Fonarow G.C., McGuire D.K., et al. Glucagon-like peptide 1 receptor agonists and heart failure the need for further evidence generation and practice guidelines optimization. Circulation. 2020;142:1205–1218. - PubMed
    1. Honka H., Solis-Herrera C., Triplite C., Norton L., Butler J., DeFronzo R.A. Therapeutic manipulation of myocardial metabolism: JACC state-of-the-art review. J Am Col Cardiol. 2021;77:2022–2039. - PMC - PubMed
    1. Punjabi M., Kosareva A., Xu L., et al. Liraglutide lowers endothelial vascular cell adhesion molecule-1 in murine atherosclerosis independent of glucose levels. J Am Coll Cardiol Basic Trans Science. 2023;8:189–200. - PMC - PubMed
    1. Nikolaou P.E., Mylonas N., Makridakis M., et al. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect? Basic Res Cardiol. 2022;117:27. - PubMed

Publication types

LinkOut - more resources